Hepatocellular Carcinoma Flashcards
What is hepatocellular carcinoma (HCC)?
It is defined as a primary liver cancer that originates from the hepatocyte cells
What is the most common primary liver cancer?
Hepatocellular carcinoma
What are the nine risk factors associated with hepatocellular carcinoma?
Male Gender
Non-Caucasian Ethnic Origin
Family History
Liver Cirrhosis
Viral Hepatitis B
Viral Hepatitis C
Alcoholic Liver Disease
Non-Alcoholic Fatty Liver Disease
Haemochromatosis
Aflatoxin
What are the two most common risk factors of hepatocellular carcinoma?
Viral Hepatitis B
Viral Hepatitis C
What are the five clinical features associated with hepatocellular carcinoma?
Abdominal Pain
Jaundice
Nausea & Vomiting
Weight Loss
Pruritis
What three investigations are used to diagnose hepatocellular carcinoma?
Blood Tests
Ultrasound Scan
CT/MRI Scans
What six blood test results indicate hepatocellular carcinoma?
Increased Alpha-Fetoprotein Levels
Increased ALT Levels
Increased AST Levels
Increased ALP Levels
Increased Gamma GT Levels
Increased Bilirubin Levels
Which tumour marker is associated with hepatocellular carcinoma?
Alpha-fetoprotein
What is the feature of hepatocellular carcinoma on ultrasound scan?
A hypoechoic lesion
What is the gold standard investigation used to diagnose hepatocellular carcinoma?
CT/MRI scan
How are CT/MRI scans used to investigate hepatocellular carcinoma?
It is used to confirm the findings established on ultrasound and to determine the staging
Which additional CT/MRI scan should be conducted in suspected hepatocellular carcinoma? Why?
Pelvic CT/MRI
To examine the testes
This is due to the fact that testicular tumours are associated with elevated alpha-fetoprotein levels
Why should liver biopsies not be conducted in suspected hepatocellular carcinomas?
The cancer cells can seed along the biopsy tract and cause local recurrence
What is the pharmacological management option of hepatocellular carcinoma?
Tyrosine kinase inhibitors
Name three tyrosine kinase inhibitors used to manage hepatocellular carcinoma
Sorafenib
Regorafenib
Lenvatinib